 |
Meet the Editors |
 |
| Meet our Series Editors in Chief , Martin L. Yarmush and Robert S. Langer, and read our Methods in Bioengineering Series description. |
 |
 |
 |
| Meet the Editors |
 |
 |
Preview
Series Pages |
 |
| Get a glimpse of what makes the Methods in Bioengineering Series so unique: consistent presentation of step-by step laboratory instructions with full-color images and supporting text. |
 |
 |
 |
| Preview series pages |
 |
| View current savings offers on book titles in the Methods in Bioengineering Series. |
 |
 |
 |
| View series savings |
 |
 |
Sign up for
Series Alerts |
 |
| Enter your email address below and be among the first to learn about new titles in the Methods in Bioengineering Series. |
 |
 |
 |
|
|
|
 |
 |
 |
|
 |
 |
Chapter 9
Magnetic Nanoparticles for Drug Delivery
| 9.1 |
 |
Introduction |
| 9.2 |
Experimental Design |
| 9.3 |
Materials |
| 9.3.1 |
Reagents |
| 9.3.2 |
Facilities/Equipment |
| 9.4 |
Methods |
| 9.4.1 |
Synthesis of Magnetic Nanoparticles |
| 9.4.2 |
Physical Characterization of Magnetic Nanoparticles |
| 9.4.3 |
Conversion of Dox·Hcl |
| 9.4.3.1 |
Convert Dox·Hcl into Water-Insoluble Doxorubicin |
| 9.4.3.2 |
Doxorubicin in Solution |
| 9.4.4 |
Drug Loading and Release Kinetics |
| 9.4.4.1 |
Drug Loading |
| 9.4.4.2 |
Determine Drug Loading |
| 9.4.5 |
Kinetics of Dox Release from Magnetic Nanoparticles |
| 9.4.6 |
Anti-Proliferative Activity of Doxorubicin Loaded Magnetic Nanoparticles on Mcf-7 Cells |
| 9.4.7 |
Anti-Proliferative Activity of Doxorubicin Loaded Magnetic Nanoparticles on Mcf-7 Cells In The Presence Of A Magnetic Field |
| 9.5 |
Data Acquisition, Anticipated Results, and Interpretation |
| 9.6 |
Discussion and Commentary |
| 9.7 |
Troubleshooting Table |
| 9.8 |
Application Notes |
| 9.9 |
Summary Points |
| |
Acknowledgement |
| |
Annotated References |
|
Chapter 10
Imaging and Therapy of Atherosclerotic Lesions with Theranostic Nanoparticles
| 10.1 |
 |
Introduction |
| 10.2 |
Experimental Design |
| 10.3 |
Materials |
| 10.3.1 |
Reagents |
| 10.3.2 |
Facilities/Equipment |
| 10.3.3 |
Animal Model |
| 10.3.4 |
Alternate Reagents And Equipment |
| 10.4 |
Methods |
| 10.4.1 |
Synthesis of Theranostic Nanoparticles |
| 10.4.2 |
Intravital Fluorescence Microscopy |
| 10.4.3 |
Light-Based Therapy |
| 10.5 |
Data Acquisition, Anticipated Results, And Interpretation |
| 10.5.1 |
Characterization of Theranostic Nanoparticles |
| 10.5.2 |
Animal Experimentation |
| 10.5.3 |
Intravital Fluorescence Microscopy |
| 10.5.4 |
Statistical Analyses |
| 10.5.5 |
Anticipated Results |
| 10.6 |
Discussion and Commentary |
| 10.7 |
Troubleshooting Table |
| 10.8 |
Summary Points |
| 10.9 |
Acknowledgements |
| 10.10 |
References |
Previous Chapter | Next Chapter
|
 |
|